Logo-apb
Adv Pharm Bull. 2016;6(3): 461-465. doi: 10.15171/apb.2016.060
PMID: 27766232        PMCID: PMC5071811

Short Communication

Synergic Antibacterial Effect of Curcumin with Ampicillin; Free Drug Solutions in Comparison with SLN Dispersions

Faezeh Alihosseini 1, Shirzad Azarmi 2,3, Solmaz Ghaffari 1,4 * , Setareh Haghighat 5, Seyed Mahdi Rezayat Sorkhabadi 6,7

Cited by CrossRef: 15


1- Khezri K, Saeedi M, Mohammadamini H, Zakaryaei A. A comprehensive review of the therapeutic potential of curcumin nanoformulations. Phytotherapy Research. 2021;35(10):5527 [Crossref]
2- Rashid Dar R, Ali A, Ahmad S, Kumar Singh S, Patra M, Panigrahi M, Kumar H, Krishnaswamy N. Immunomodulatory effect of curcumin on lipopolysaccharide‐ and/or flagellin‐induced production of prostaglandin E2 and relative expression of proinflammatory cytokines in the primary bubaline endometrial stromal cells. Reprod Domestic Animals. 2019;54(6):917 [Crossref]
3- de Souza M, dos Santos W, de Sousa A, de Albuquerque Wanderley Sales V, Nóbrega F, de Oliveira M, Rolim-Neto P. Lipid Nanoparticles as a Skin Wound Healing Drug Delivery System: Discoveries and Advances. CPD. 2020;26(36):4536 [Crossref]
4- Javanmard Z, Pourhajibagher M, Bahador A. Characteristics and Applications of Peptide Nucleic Acid in the Treatment of Infectious Diseases and the Effect of Antimicrobial Photodynamic Therapy on Treatment Effectiveness. IDDT. 2024;24(1) [Crossref]
5- Arana L, Gallego L, Alkorta I. Incorporation of Antibiotics into Solid Lipid Nanoparticles: A Promising Approach to Reduce Antibiotic Resistance Emergence. Nanomaterials. 2021;11(5):1251 [Crossref]
6- Abbo H, Yufanyi D, Shah T, Khaligh N, Chinnam S, Efferth T, Titinchi S. Curcuminoid Nanovesicles as Advanced Therapeutics. ChemBioEng Reviews. 2023;10(6):1083 [Crossref]
7- Liu S, Zheng S, Hou A, Zhang J, Wang S, Wang X, Yu H, Yang L. A Review. 2022;8(4):463 [Crossref]
8- Taheri M, Arabestani M, Kalhori F, Soleimani Asl S, Asgari M, Hosseini S. Antibiotics-encapsulated nanoparticles as an antimicrobial agent in the treatment of wound infection. Front Immunol. 2024;15 [Crossref]
9- Sharifi S, Fathi N, Memar M, Hosseiniyan Khatibi S, Khalilov R, Negahdari R, Zununi Vahed S, Maleki Dizaj S. Anti‐microbial activity of curcumin nanoformulations: New trends and future perspectives. Phytotherapy Research. 2020;34(8):1926 [Crossref]
10- Rauf A, Imran M, Orhan I, Bawazeer S. Health perspectives of a bioactive compound curcumin: A review. Trends in Food Science & Technology. 2018;74:33 [Crossref]
11- Ghaffari S, Alihosseini F, Rezayat Sorkhabadi S, Arbabi Bidgoli S, Mousavi S, Haghighat S, Afshar Nasab A, Kianvash N. Nanotechnology in Wound Healing; Semisolid Dosage Forms Containing Curcumin-Ampicillin Solid Lipid Nanoparticles, in-Vitro, Ex-Vivo and in-Vivo Characteristics. Adv Pharm Bull. 2018;8(3):395 [Crossref]
12- Ali A, Dar R, Ahmad S, Singh S, Patra M, Panigrahi M, Kumar H, Krishnaswamy N. Curcumin inhibits lipopolysaccharide and lipoteichoic acid-induced expression of proinflammatory cytokines and production of PGE2 in the primary bubaline endometrial stromal cells. Mol Biol Rep. 2020;47(12):10015 [Crossref]